サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1586417

オルガノイドとスフェロイド市場、シェア、規模、動向、産業分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024-2032年

Organoids and Spheroids Market Share, Size, Trends, Industry Analysis Report - By Type (Organoids and Spheroids), Application, End Use, and Region; Segment Forecasts, 2024-2032

出版日
ページ情報
英文 116 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
オルガノイドとスフェロイド市場、シェア、規模、動向、産業分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024-2032年
出版日: 2024年10月01日
発行: Polaris Market Research
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、オルガノイドとスフェロイドの世界市場規模は2032年までに51億1,759万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

CRISPR/Cas-9のような遺伝子編集技術の開発により、研究者は幹細胞の遺伝子に正確な変更を加えることができるようになり、疾患状態を再現するオルガノイドとスフェロイドの作製につながっています。このような進歩は、複雑な細胞状態に関する貴重な洞察をもたらし、疾患研究や薬剤試験のための改良されたモデルを研究者に提供しました。幹細胞技術と3D培養法の進歩の組み合わせが、オルガノイドとスフェロイド市場の着実な成長に重要な役割を果たしています。2024年1月、USCの研究者たちは、小脳の発生と神経疾患における小脳病理の出現を研究するための新しいヒト脳オルガノイドモデルを開発しました。

患者特異的なオルガノイドは、個別化医療を推進するための強固なプラットフォームであり、患者から採取した組織で潜在的な薬剤の試験を可能にすることで、オルガノイドとスフェロイド市場の成長を牽引しています。研究と臨床の両方におけるオルガノイドとスフェロイドの臨床的重要性は、個別化オルガノイド・モデルを開発し、P4医療の進展を促進する上で極めて重要です。

3Dバイオプリンティング技術とorgan-on-a-chipプラットフォームの開発は、オルガノイドとスフェロイドの研究を大きく前進させる。3Dバイオプリンティングは、複雑でカスタマイズされた組織モデルを高い精度で作成することを可能にし、薬剤検査や個別化医療を強化します。Organ-on-a-chipプラットフォームは、臓器機能をミニチュアで再現し、ダイナミックなモデリング、ハイスループットスクリーニング、個別化治療戦略を可能にします。これらの技術革新により、生物医学研究の精度と妥当性が向上し、より効果的な医薬品開発と疾患理解が促進されます。

オルガノイドとスフェロイド市場レポートハイライト

タイプ別では、創薬と疾患モデリングにおける重要な用途のため、スフェロイドセグメントが2023年に大きなシェアを占めています。

オルガノイドセグメントは、がん、神経変性疾患、感染症などの疾患の発生が増加し、高度な研究モデルの需要が高まっていることから、予測期間中に急成長すると予測されています。

用途別では、発生生物学分野が器官形成メカニズムへの応用により、2023年の市場を独占しました。

北米が2023年に最大のシェアを占めているが、これはオルガノイドとスフェロイドの個別化医療への利用が増加しているためです。

主要企業は、3D Biomatrix、3D Biotek、AMS Biotechnology、Cellsce、Greiner Bio-One、Thermo Fisher Scientificなどです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のオルガノイドとスフェロイド市場の洞察

  • 市場スナップショット
  • オルガノイドとスフェロイドの市場力学
    • 促進要因と機会
      • 幹細胞調査の進歩
      • 創薬と個別化医療への応用拡大
    • 抑制要因と課題
      • 開発と生産のコストが高い
  • PESTEL分析
  • オルガノイドとスフェロイドの市場アプリケーション動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のオルガノイドとスフェロイド市場：タイプ別

  • 主な調査結果
  • イントロダクション
  • オルガノイド
  • スフェロイド

第6章 世界のオルガノイドとスフェロイド市場：用途別

  • 主な調査結果
  • イントロダクション
  • 発生生物学
  • パーソナライズ医療
  • 再生医療
  • 疾患病理学研究
  • 薬物毒性および有効性試験

第7章 世界のオルガノイドとスフェロイド市場：最終用途別

  • 主な調査結果
  • イントロダクション
  • バイオテクノロジーおよび製薬産業
  • 学術調査機関
  • 病院と診断センター

第8章 世界のオルガノイドとスフェロイド市場：地域別

  • 主な調査結果
  • イントロダクション
    • オルガノイドとスフェロイドの市場評価：地域、2019年～2032年年
  • 北米
    • 北米：タイプ別、2019年～2032年年
    • 北米：用途別、2019年～2032年年
    • 北米：最終用途別、2019年～2032年
    • 米国
    • カナダ
  • 欧州
    • 欧州：タイプ別、2019年～2032年
    • 欧州：用途別、2019年～2032年年
    • 欧州：最終用途別、2019年～2032年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋地域：タイプ別、2019年～2032年
    • アジア太平洋地域：用途別、2019年～2032年年
    • アジア太平洋地域：最終用途別、2019年～2032年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：タイプ別、2019年～2032年
    • 中東・アフリカ：用途別、2019年～2032年年
    • 中東・アフリカ：最終用途別、2019～2032年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：タイプ別、2019年～2032年年
    • ラテンアメリカ：用途別、2019年～2032年年
    • ラテンアメリカ：最終用途別、2019年～2032年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • 3D Biomatrix
  • 3D Biotek LLC
  • AMS Biotechnology Limited
  • Cellesce Ltd.
  • TheWell Bioscience
  • Greiner Bio-One
  • Hubrecht Organoid Technology（HUB）
  • InSphero
  • Lonza
  • Merck KGaA
  • Prellis Biologics
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific, Inc.
図表

List of Tables:

  • Table 1 Global Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 2 Global Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 3 Global Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 4 North America: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 5 North America: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 6 North America: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 7 U.S.: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 8 U.S.: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 9 U.S.: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 10 Canada: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 11 Canada: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 12 Canada: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 13 Europe: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 14 Europe: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 15 Europe: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 16 UK: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 17 UK: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 18 UK: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 19 France: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 20 France: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 21 France: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 22 Germany: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 23 Germany: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 24 Germany: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 25 Italy: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 26 Italy: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 27 Italy: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 28 Spain: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 29 Spain: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 30 Spain: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 31 Netherlands: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 32 Netherlands: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 33 Netherlands: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 34 Russia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 35 Russia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 36 Russia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 37 Rest of Europe: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 38 Rest of Europe: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 39 Rest of Europe: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 41 Asia Pacific: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 42 Asia Pacific: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 43 China: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 44 China: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 45 China: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 46 India: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 47 India: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 48 India: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 49 Malaysia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 50 Malaysia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 51 Malaysia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 52 Japan: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 53 Japan: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 54 Japan: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 55 Indonesia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 56 Indonesia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 57 Indonesia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 58 South Korea: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 59 South Korea: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 60 South Korea: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 61 Australia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 62 Australia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 63 Australia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 64 Rest of Asia Pacific: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 65 Rest of Asia Pacific: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 66 Rest of Asia Pacific: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 67 Middle East & Africa: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 68 Middle East & Africa: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 69 Middle East & Africa: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 70 Saudi Arabia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 71 Saudi Arabia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 72 Saudi Arabia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 73 UAE: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 74 UAE: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 75 UAE: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 76 Israel: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 77 Israel: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 78 Israel: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 79 South Africa: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 80 South Africa: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 81 South Africa: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 82 Rest of Middle East & Africa: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 83 Rest of Middle East & Africa: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 84 Rest of Middle East & Africa: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 85 Latin America: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 86 Latin America: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 87 Latin America: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 88 Mexico: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 89 Mexico: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 90 Mexico: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 91 Brazil: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 92 Brazil: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 93 Brazil: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 94 Argentina: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 95 Argentina: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 96 Argentina: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 97 Rest of Latin America: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 98 Rest of Latin America: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 99 Rest of Latin America: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • List of Figures:
  • Figure 1. Global Organoids and Spheroids Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Organoids and Spheroids Market, by Type, 2023 & 2032 (USD Million)
  • Figure 8. Market by Application
  • Figure 9. Global Organoids and Spheroids Market, by Application, 2023 & 2032 (USD Million)
  • Figure 10. Market by End Use
  • Figure 11. Global Organoids and Spheroids Market, by End Use, 2023 & 2032 (USD Million)
目次
Product Code: PM1782

The global organoids and spheroids market size is expected to reach USD 5,117.59 million by 2032, according to a new study by Polaris Market Research. The report "Organoids and Spheroids Market Share, Size, Trends, Industry Analysis Report - By Type, Application, End Use, and Region; Segment Forecasts, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The development of genetic editing techniques such as CRISPR/Cas-9 has enabled researchers to make precise changes to genes in stem cells, leading to the creation of organoids and spheroids that replicate disease conditions. These advancements have provided researchers with improved models for studying diseases and testing drugs, yielding valuable insights into complex cellular conditions. The combination of progress in stem cell technology and 3D culture methods has played a crucial role in the steady growth of the organoids and spheroids market. In January 2024, USC researchers developed a new human brain organoid model to study cerebellum development and the emergence of cerebellar pathology in neurological disease.

Patient-specific organoids represent a robust platform for advancing personalized medicine and driving the growth of the organoids and spheroids market by enabling the testing of potential drugs on tissues sourced from patients, which provides valuable insights into individual therapy responses. The clinical importance of organoids and spheroids in both research and clinical practice is crucial for developing personalized organoid models and furthering the progress of P4 medicine.

The development of 3D bioprinting technologies and organ-on-a-chip platforms significantly advances organoid and spheroid research. 3D bioprinting enables the creation of complex, customized tissue models with high precision, enhancing drug testing and personalized medicine. Organ-on-a-chip platforms replicate organ functions in miniature, allowing for dynamic modeling, high-throughput screening, and personalized treatment strategies. Together, these innovations improve the accuracy and relevance of biomedical research, facilitating more effective drug development and disease understanding.

Organoids and Spheroids Market Report Highlights

Based on type, the spheroids segment held a larger share in 2023, owing to their significant use in drug discovery and disease modeling.

The organoids segment is projected to grow rapidly during the forecast period, fueled by rising occurrences of diseases such as cancer, neurodegenerative disorders, and infectious diseases, driving demand for advanced research models.

By application, the developmental biology segment dominated the market in 2023, owing to its application in the mechanism of organogenesis.

North America holds the largest share in 2023, owing to the rising use of organoids and spheroids for personalized medicine.

A few key players are 3D Biomatrix, 3D Biotek, AMS Biotechnology, Cellesce, Greiner Bio-One, and Thermo Fisher Scientific.

Polaris Market Research has segmented the organoids and spheroids market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue - USD million, 2019-2032)

  • Organoids
  • By Type
  • Neural Organoids
  • Hepatic Organoids
  • Intestinal Organoids
  • Other Organoids
  • By Method
  • General Submerged Method for Organoid Culture
  • Crypt Organoid Culture Techniques
  • Air Liquid Interface (ALI) Method for Organoid Culture
  • Clonal Organoids from Lgr5+ Cells
  • Brain and Retina Organoid Formation Protocol
  • Others
  • By Source
  • Primary Tissues
  • Stem Cells
  • Spheroids
  • By Type
  • Multicellular Tumor Spheroids (MCTS)
  • Neurospheres
  • Mammospheres
  • Hepatospheres
  • Embryoid Bodies
  • By Method
  • Micropatterned Plates
  • Low Cell Attachment Plates
  • Hanging Drop Method
  • Others
  • By Source
  • Cell Line
  • Primary Cell
  • iPSCs Derived Cells

By Application Outlook (Revenue - USD million, 2019-2032)

  • Developmental Biology
  • Personalized Medicine
  • Regenerative Medicine
  • Disease Pathology Studies
  • Drug Toxicity & Efficacy Testing

By End Use Outlook (Revenue - USD million, 2019-2032)

  • Biotechnology & Pharmaceutical Industries
  • Academic & Research Institutes
  • Hospitals & Diagnostic Centers

By Regional Outlook (Revenue - USD million, 2019-2032)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Organoids and Spheroids Market Insights

  • 4.1. Organoids and Spheroids Market - Market Snapshot
  • 4.2. Organoids and Spheroids Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancement in stem cell research
      • 4.2.1.2. Increased application in drug discovery and personalized medicine
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of development and Production
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Organoids and Spheroids Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Organoids and Spheroids Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • 5.3. Organoids
    • 5.3.1. Global Organoids and Spheroids Market, by Organoids, by Region, 2019-2032 (USD Million)
  • 5.4. Spheroids
    • 5.4.1. Global Organoids and Spheroids Market, by Spheroids, by Region, 2019-2032 (USD Million)

6. Global Organoids and Spheroids Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • 6.3. Developmental Biology
    • 6.3.1. Global Organoids and Spheroids Market, by Developmental Biology, by Region, 2019-2032 (USD Million)
  • 6.4. Personalized Medicine
    • 6.4.1. Global Organoids and Spheroids Market, by Personalized Medicine, by Region, 2019-2032 (USD Million)
  • 6.5. Regenerative Medicine
    • 6.5.1. Global Organoids and Spheroids Market, by Regenerative Medicine, by Region, 2019-2032 (USD Million)
  • 6.6. Disease Pathology Studies
    • 6.6.1. Global Organoids and Spheroids Market, by Disease Pathology Studies, by Region, 2019-2032 (USD Million)
  • 6.7. Drug Toxicity & Efficacy Testing
    • 6.7.1. Global Organoids and Spheroids Market, by Drug Toxicity & Efficacy Testing, by Region, 2019-2032 (USD Million)

7. Global Organoids and Spheroids Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • 7.3. Biotechnology & Pharmaceutical Industries
    • 7.3.1. Global Organoids and Spheroids Market, by Biotechnology & Pharmaceutical Industries, by Region, 2019-2032 (USD Million)
  • 7.4. Academic & Research Institutes
    • 7.4.1. Global Organoids and Spheroids Market, by Academic & Research Institutes, by Region, 2019-2032 (USD Million)
  • 7.5. Hospitals & Diagnostic Centers
    • 7.5.1. Global Organoids and Spheroids Market, by Hospitals & Diagnostic Centers, by Region, 2019-2032 (USD Million)

8. Global Organoids and Spheroids Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Organoids and Spheroids Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Organoids and Spheroids Market - North America
    • 8.3.1. North America: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
    • 8.3.3. North America: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.3.4. Organoids and Spheroids Market - U.S.
      • 8.3.4.1. U.S.: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.3.5. Organoids and Spheroids Market - Canada
      • 8.3.5.1. Canada: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • 8.4. Organoids and Spheroids Market - Europe
    • 8.4.1. Europe: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
    • 8.4.2. Europe: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
    • 8.4.3. Europe: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.4. Organoids and Spheroids Market - UK
      • 8.4.4.1. UK: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.5. Organoids and Spheroids Market - France
      • 8.4.5.1. France: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.5.2. France: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.5.3. France: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.6. Organoids and Spheroids Market - Germany
      • 8.4.6.1. Germany: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.7. Organoids and Spheroids Market - Italy
      • 8.4.7.1. Italy: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.8. Organoids and Spheroids Market - Spain
      • 8.4.8.1. Spain: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.9. Organoids and Spheroids Market - Netherlands
      • 8.4.9.1. Netherlands: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.10. Organoids and Spheroids Market - Russia
      • 8.4.10.1. Russia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.11. Organoids and Spheroids Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.11.2. Rest of Europe: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.11.3. Rest of Europe: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • 8.5. Organoids and Spheroids Market - Asia Pacific
    • 8.5.1. Asia Pacific: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.4. Organoids and Spheroids Market - China
      • 8.5.4.1. China: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.4.2. China: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.4.3. China: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.5. Organoids and Spheroids Market - India
      • 8.5.5.1. India: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.5.2. India: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.5.3. India: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.6. Organoids and Spheroids Market - Malaysia
      • 8.5.6.1. Malaysia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.7. Organoids and Spheroids Market - Japan
      • 8.5.7.1. Japan: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.8. Organoids and Spheroids Market - Indonesia
      • 8.5.8.1. Indonesia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.9. Organoids and Spheroids Market - South Korea
      • 8.5.9.1. South Korea: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.10. Organoids and Spheroids Market - Australia
      • 8.5.10.1. Australia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.10.2. Australia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.10.3. Australia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.11. Organoids and Spheroids Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • 8.6. Organoids and Spheroids Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.6.4. Organoids and Spheroids Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.6.5. Organoids and Spheroids Market - UAE
      • 8.6.5.1. UAE: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.6.6. Organoids and Spheroids Market - Israel
      • 8.6.6.1. Israel: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.6.7. Organoids and Spheroids Market - South Africa
      • 8.6.7.1. South Africa: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.6.8. Organoids and Spheroids Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • 8.7. Organoids and Spheroids Market - Latin America
    • 8.7.1. Latin America: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.7.4. Organoids and Spheroids Market - Mexico
      • 8.7.4.1. Mexico: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.7.5. Organoids and Spheroids Market - Brazil
      • 8.7.5.1. Brazil: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.7.6. Organoids and Spheroids Market - Argentina
      • 8.7.6.1. Argentina: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.7.7. Organoids and Spheroids Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.7.7.2. Rest of Latin America: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.7.7.3. Rest of Latin America: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. 3D Biomatrix
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Type Benchmarking
    • 10.1.4. Recent Development
  • 10.2. 3D Biotek LLC
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Type Benchmarking
    • 10.2.4. Recent Development
  • 10.3. AMS Biotechnology Limited
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Type Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Cellesce Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Type Benchmarking
    • 10.4.4. Recent Development
  • 10.5. TheWell Bioscience
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Type Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Greiner Bio-One
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Type Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Hubrecht Organoid Technology (HUB)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Type Benchmarking
    • 10.7.4. Recent Development
  • 10.8. InSphero
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Type Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Lonza
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Type Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Merck KGaA
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Type Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Prellis Biologics
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Type Benchmarking
    • 10.11.4. Recent Development
  • 10.12. STEMCELL Technologies Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Type Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Thermo Fisher Scientific, Inc.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Type Benchmarking
    • 10.13.4. Recent Development